See also this year's filing and all EDGAR filings for this company.
PDF Report 0001505512_2022_Regulus_Therapeutics_Inc.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
Graph
Absolute values for 0001505512, Regulus Therapeutics Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 65,235,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 83,000 |
| 2 | PropertyPlantAndEquipmentNet | 0 |
| 3 | remainder_Assets | 3,136,000 |
| 4 | LiabilitiesCurrent | 5,227,000 |
| 5 | LiabilitiesNoncurrent | 8,269,000 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 11,051,075 |
| 9 | ResearchAndDevelopmentExpense | 20,821,132 |
| 10 | remainder_Expenses | -95,551 |
| 11 | remainder_Revenues | 3,644,917 |
| 12 | remainder_NetIncome | 0 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 68,454,000 |
| 1 | Liabilities | 13,496,000 |
| 2 | Expenses | 31,776,656 |
| 3 | Revenues | 3,644,917 |
| 4 | StockholdersEquity | 54,958,000 |
| 5 | NetIncome | -28,131,739 |
| 6 | ComprehensiveNetIncome | -28,131,739 |
| 7 | BaseVar | 58,685,786 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 2.24 |
| 9 | EconomicCapitalRatio | 3.18 |